NO920050L - Trifluormetyl-1-karba(1-detia)cefemer - Google Patents

Trifluormetyl-1-karba(1-detia)cefemer

Info

Publication number
NO920050L
NO920050L NO92920050A NO920050A NO920050L NO 920050 L NO920050 L NO 920050L NO 92920050 A NO92920050 A NO 92920050A NO 920050 A NO920050 A NO 920050A NO 920050 L NO920050 L NO 920050L
Authority
NO
Norway
Prior art keywords
carba
cephem
trifluoromethyl
dethia
antibiotics
Prior art date
Application number
NO92920050A
Other languages
English (en)
Other versions
NO920050D0 (no
Inventor
Gwendolyn Kay Cook
William Joseph Hornback
Iii John Hampton Mcdonald
John Edwin Munroe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO920050D0 publication Critical patent/NO920050D0/no
Publication of NO920050L publication Critical patent/NO920050L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

7-B-acylamlno-l-karba-(l-det l a)-3-tri fluormetyl-3- cefem-4-karboksylsyre og derivater er tilveiebrakt som antibiotika. Farmasøytiske formuleringer som omfatter antibiotikaene, mellomproduktene og en fremgangsmåte for fremstilling, er også tilveiebrakt.
NO92920050A 1991-01-10 1992-01-03 Trifluormetyl-1-karba(1-detia)cefemer NO920050L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/639,475 US5099015A (en) 1991-01-10 1991-01-10 Trifluoromethyl 1-carba(1-dethia)cephems

Publications (2)

Publication Number Publication Date
NO920050D0 NO920050D0 (no) 1992-01-03
NO920050L true NO920050L (no) 1992-07-13

Family

ID=24564249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920050A NO920050L (no) 1991-01-10 1992-01-03 Trifluormetyl-1-karba(1-detia)cefemer

Country Status (21)

Country Link
US (1) US5099015A (no)
EP (1) EP0494733A1 (no)
JP (1) JPH05140160A (no)
KR (1) KR920014809A (no)
CN (1) CN1063104A (no)
AU (1) AU640072B2 (no)
BR (1) BR9200004A (no)
CA (1) CA2058699A1 (no)
CS (1) CS792A3 (no)
FI (1) FI920019A (no)
HU (1) HUT60267A (no)
IE (1) IE920021A1 (no)
IL (1) IL100573A (no)
MX (1) MX9200017A (no)
NO (1) NO920050L (no)
NZ (1) NZ241160A (no)
PT (1) PT99969A (no)
RU (1) RU2089551C1 (no)
TW (1) TW213912B (no)
YU (1) YU200791A (no)
ZA (1) ZA9222B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305837D0 (en) * 1993-03-20 1993-05-05 Smithkline Beecham Plc Novel compounds
US5525599A (en) * 1993-07-21 1996-06-11 Eli Lilly And Company 7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids
US20050245498A1 (en) * 2002-05-14 2005-11-03 Shoichet Brian K Sterically-awkward beta-lactamase inhibitors
US20030236243A1 (en) * 2002-05-14 2003-12-25 Shoichet Brian K. Sterically-awkward beta-lactamase inhibitors
WO2007034924A1 (ja) * 2005-09-22 2007-03-29 Meiji Seika Kaisha, Ltd. メタロ－β－ラクタマーゼ阻害剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347367A (en) * 1977-10-19 1982-08-31 Merck & Co., Inc. 3-Substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
NO155547C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling.
NO802713L (no) * 1979-09-13 1981-03-16 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av racemiske eller optisk aktive cefalosporin-analoge karbacefemforbindelser eller farmaseutisk akseptable salter derav
JPS5842860B2 (ja) * 1979-10-12 1983-09-22 三菱瓦斯化学株式会社 ２−ペンテン酸エステルの製造方法
DK389180A (da) * 1979-10-25 1981-04-26 Kyowa Hakko Kogyo Kk Optisk aktive cephalosporin-analoge carbacephemforbindelser og salte deraf samt fremgangsmaade til fremstilling deraf
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd ３位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
US4708956A (en) * 1985-12-12 1987-11-24 Kyowa Hakko Kogyo Co., Ltd. 3-position halogenated cephalosporin analogs and pharmaceutical compositions
DE3880229T2 (de) * 1987-07-31 1993-08-12 Lilly Co Eli Verfahren zum entschuetzen von 3-aminoazetidinonen.
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln

Also Published As

Publication number Publication date
US5099015A (en) 1992-03-24
AU640072B2 (en) 1993-08-12
FI920019A0 (fi) 1992-01-02
ZA9222B (en) 1993-07-02
CA2058699A1 (en) 1992-07-11
BR9200004A (pt) 1992-09-08
IL100573A (en) 1997-01-10
NZ241160A (en) 1994-04-27
NO920050D0 (no) 1992-01-03
JPH05140160A (ja) 1993-06-08
TW213912B (no) 1993-10-01
MX9200017A (es) 1992-07-01
IE920021A1 (en) 1992-07-15
PT99969A (pt) 1993-02-26
HUT60267A (en) 1992-08-28
HU9200011D0 (en) 1992-03-30
KR920014809A (ko) 1992-08-25
IL100573A0 (en) 1992-09-06
CN1063104A (zh) 1992-07-29
FI920019A (fi) 1992-07-11
EP0494733A1 (en) 1992-07-15
YU200791A (sh) 1994-01-20
AU1001192A (en) 1992-07-16
CS792A3 (en) 1992-07-15
RU2089551C1 (ru) 1997-09-10

Similar Documents

Publication Publication Date Title
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
NO984290L (no) Farmas°ytisk nyttige forbindelser
DK72289A (da) Cephemcarboxylsyreestere, deres fremstilling og anvendelse
IT1227072B (it) Clavulanato di potassio, procedimento per la sua produzione e composizione farmaceutica
NO920050L (no) Trifluormetyl-1-karba(1-detia)cefemer
DK118386D0 (da) Beta-lactam-antibiotika, deres fremstilling og anvendelse som laegemidler
DK0402806T3 (da) Krystallinske cephem-syreadditionssalte og fremgangsmåde til fremstilling heraf
DK1017681T3 (da) Hydrazon-benzazulenderivater, farmaceutiske præparater og mellemprodukter
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
NO992225L (no) FremgangsmÕte for fremstilling av salter og estere av klavulansyre
MY114213A (en) Clavulanic acid salts
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
NO864475D0 (no) Cefalosporinderivater og fremgangsmaate til deres fremstilling.
FI871479A (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
NO975526D0 (no) Nye laksativpreparater og fremgangsmåte for fremstilling av slike
PT93581A (pt) Processo para a preparacao de derivados cefalosporanicos e de composicoes farmaceuticas que os contem
DK73487D0 (da) Antibiotika af streptogramin-type, mikrobiologisk fremgangsmaade til fremstilling og deres anvendelse som laegemidler og fodertilsaetningsmidler
IT8721157A0 (it) Composto terapeuticamente utile, procedimento per la sua preparazione e relative composizioni farmaceutiche.